As winter begins, ECDC is issuing advice to policymakers and public health authorities to protect infants from RSV with immunisation and other preventive measures.
This executive summary sets out results derived from 2024 antimicrobial resistance (AMR) data, sourced from invasive isolates reported to both the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net).
In 2025, all European Union/European Economic Area (EU/EEA) countries reported data for 2024 to the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Antimicrobial resistance (AMR) is considered one of the main threats to public health in the EU and the EEA, with over 35 000 deaths attributable to infections with antibiotic-resistant bacteria estimated in 2020. Antimicrobial use exerts ecological pressure on bacteria and contributes to the emergence and selection of resistant types, which is why ensuring prudent antimicrobial use is the key to an effective response to AMR.
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.
